View Article

Abstract

Artificial Intelligence (AI) is revolutionizing pharmaceutical sciences by enabling rapid, accurate, and cost-effective drug delivery system (DDS) design and optimization. Conventional formulation development relies heavily on trial-and-error experimentation, which is time-consuming and resource-intensive. AI technologies such as machine learning (ML), deep learning (DL), artificial neural networks (ANN), and predictive analytics are transforming formulation development by predicting drug behavior, optimizing excipient selection, improving drug targeting, and enhancing therapeutic outcomes. AI-driven approaches are widely applied in nanotechnology-based drug delivery, personalized medicine, controlled release systems, and smart drug delivery platforms. This review discusses the role of AI in DDS design, optimization strategies, current applications, advantages, challenges, and future perspectives in pharmaceutics. Recent studies indicate that AI significantly accelerates pharmaceutical innovation while reducing development costs and experimental failures.

Keywords

Artificial Intelligence (AI); Drug Delivery Systems (DDS); Machine Learning (ML); Deep Learning (DL); Artificial Neural Networks (ANN); Pharmaceutics; Formulation Optimization; Predictive Analytics; Nanotechnology-Based Drug Delivery; Personalized Medicine.

Introduction

× Popup Image

Drug delivery systems are essential for improving therapeutic efficacy, reducing toxicity, and enhancing patient compliance. Traditional formulation development methods involve extensive experimental trials that require substantial time, labor, and financial investment. In recent years, AI has emerged as a transformative technology in pharmaceutical sciences, particularly in drug delivery system design and optimization. AI refers to computational systems capable of simulating human intelligence for learning, prediction, and decision-making. Machine learning and deep learning algorithms can analyze large pharmaceutical datasets and predict formulation performance with high accuracy. AI enables researchers to optimize critical formulation parameters such as particle size, drug release rate, encapsulation efficiency, stability, and bioavailability. The integration of AI with advanced drug delivery technologies, including nanoparticles, liposomes, microneedles, hydrogels, and smart delivery systems, has opened new opportunities in precision medicine and personalized therapeutics. AI-driven drug delivery platforms can improve treatment outcomes while minimizing adverse effects.

2. Artificial Intelligence Technologies Used in Drug Delivery

2.1 Machine Learning (ML)

Machine learning is a subset of AI that allows systems to learn patterns from data and make predictions without explicit programming. ML algorithms are extensively used for predicting formulation properties and optimizing process variables.

Common ML algorithms used in pharmaceutics include:

  • Random Forest
  • Support Vector Machine (SVM)
  • Decision Trees
  • k-Nearest Neighbor (k-NN)
  • ML models help predict:
  • Drug release profiles
  • Solubility enhancement
  • Stability behavior
  • Nanoparticle characteristics

2.2 Artificial Neural Networks (ANN)

ANNs mimic the structure and function of the human brain. These models are widely used in pharmaceutical formulation optimization because they can process complex nonlinear relationships among variables.

Applications include:

  • Prediction of dissolution behavior
  • Optimization of polymer concentration
  • Controlled drug release modeling

2.3 Deep Learning (DL)

Deep learning employs multilayer neural networks capable of handling complex pharmaceutical datasets. DL is highly effective in image analysis, molecular modeling, and nanocarrier design.

  • DL applications include:
  • Predicting nanoparticle interactions
  • Drug targeting analysis
  • Smart biosensor integration

2.4 Reinforcement Learning

Reinforcement learning enables systems to optimize formulation strategies through repeated learning cycles. It is increasingly used in adaptive and smart drug delivery systems. 

3. AI in Drug Delivery System Design

3.1 Nanoparticle-Based Drug Delivery

Nanotechnology-based DDSs improve drug targeting and bioavailability. AI algorithms can optimize nanoparticle formulation parameters such as:

  • Particle size
  • Surface charge
  • Drug loading efficiency
  • Release kinetics

3.2 Liposomal Drug Delivery

Liposomes are phospholipid vesicles used for targeted drug delivery. AI models assist in:

  • Lipid composition optimization
  • Stability prediction
  • Encapsulation efficiency enhancement

3.3 Controlled and Sustained Release Systems

AI helps optimize polymer matrices and release modifiers for sustained drug release formulations. Predictive algorithms estimate:

  • Drug diffusion rates
  • Polymer degradation
  • Release mechanisms

This improves therapeutic efficacy and minimizes dosing frequency.

3.4 Personalized Drug Delivery

AI enables patient-specific drug delivery approaches by analyzing genetic, physiological, and pharmacokinetic data. Personalized DDSs improve treatment outcomes and reduce adverse drug reactions. 

4. AI in Drug Delivery Optimization

4.1 Formulation Optimization

AI models reduce the number of experimental trials required during formulation development. Parameters optimized include:

  • Excipient concentration
  • Mixing speed
  • Temperature

Optimization improves product quality and manufacturing efficiency.

4.2 Process Optimization

AI-assisted process analytical technology (PAT) enhances pharmaceutical manufacturing by real-time monitoring and quality prediction.

Benefits include:

  • Reduced batch failure
  • Improved reproducibility
  • Faster scale-up

4.3 Predictive Modeling

Predictive analytics help forecast:

  • Stability profiles
  • Shelf life
  • Drug release patterns
  • Bioavailability

These predictions support rapid formulation screening and regulatory compliance.

5. Applications of AI-Driven Drug Delivery Systems

5.1 Cancer Therapy

AI-driven nanocarriers improve targeted delivery of anticancer drugs while reducing systemic toxicity. Smart nanoparticles can selectively release drugs at tumor sites.

5.2 Gene Delivery

AI enhances the design of vectors for gene and mRNA delivery. Lipid nanoparticles used in mRNA therapeutics are optimized using AI techniques. 

5.3 Smart Drug Delivery Systems

Smart DDSs respond to stimuli such as:

  • pH
  • Temperature
  • Enzymes
  • Magnetic fields

AI enables closed-loop drug delivery systems capable of autonomous therapeutic regulation. 

6. Advantages of AI in Drug Delivery

Major advantages include:

  • Reduced development time
  • Lower research costs
  • Enhanced prediction accuracy
  • Improved therapeutic efficacy
  • Personalized treatment approaches
  • Reduced experimental failures

7. Challenges and Limitations

Despite its benefits, AI implementation in pharmaceutics faces several challenges:

  • Limited availability of high-quality datasets
  • Data privacy concerns
  • Regulatory uncertainty
  • High computational costs
  • Lack of standardized AI models
  • Requirement for interdisciplinary expertise

8. Future Perspectives

The future of AI-driven drug delivery is highly promising. Emerging technologies such as digital twins, explainable AI, generative AI, and autonomous drug delivery systems are expected to revolutionize pharmaceutical development.

Future advancements may include:

  • Fully automated formulation laboratories
  • Real-time adaptive drug delivery systems
  • AI-integrated wearable therapeutics
  • Precision nanomedicine
  • AI-guided clinical translation

Integration of AI with big data, biosensors, robotics, and Internet of Medical Things (IoMT) technologies may further enhance personalized medicine. 

CONCLUSION

Artificial Intelligence has become a powerful tool in drug delivery system design and optimization. AI technologies significantly improve formulation efficiency, predictive accuracy, and therapeutic outcomes while reducing development time and costs. Applications in nanotechnology, personalized medicine, gene delivery, and smart DDSs demonstrate the immense potential of AI in modern pharmaceutics. Although challenges related to data quality, regulatory frameworks, and computational requirements remain, continuous advancements in AI are expected to transform the future of pharmaceutical sciences. AI-driven drug delivery systems represent a major step toward precision medicine and next-generation therapeutics.

REFERENCES

  1. Suksaeree J. A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems. Sci. 2025.
  2. Panchpuri M, Painuli R, Kumar C. Artificial intelligence in smart drug delivery systems: a step toward personalized medicine. RSC Pharmaceutics. 2025.
  3. AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery. Critical Reviews in Oncology/Hematology. 2025.
  4. Machine learning empowered formulation design of nanoparticulate drug delivery systems. Acta Pharmaceutica Sinica B. 2025.
  5. Smart closed-loop drug delivery systems. Nature Reviews Bioengineering. 2025.

Reference

  1. Suksaeree J. A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems. Sci. 2025.
  2. Panchpuri M, Painuli R, Kumar C. Artificial intelligence in smart drug delivery systems: a step toward personalized medicine. RSC Pharmaceutics. 2025.
  3. AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery. Critical Reviews in Oncology/Hematology. 2025.
  4. Machine learning empowered formulation design of nanoparticulate drug delivery systems. Acta Pharmaceutica Sinica B. 2025.
  5. Smart closed-loop drug delivery systems. Nature Reviews Bioengineering. 2025.

Photo
Narendra Sharma
Corresponding author

Faculty of Pharmacy, Jaipur School of Pharmacy, Maharaj Vinayak Global University, Jaipur, Rajasthan, India

Photo
Vishal Garg
Co-author

Faculty of Pharmacy, Jaipur School of Pharmacy, Maharaj Vinayak Global University, Jaipur, Rajasthan, India

Photo
Pushpendra Kumar Saini
Co-author

Faculty of Pharmacy, Jaipur School of Pharmacy, Maharaj Vinayak Global University, Jaipur, Rajasthan, India

Narendra Sharma*, Vishal Garg, Pushpendra Kumar Saini, AI-Driven Drug Delivery System Design and Optimization, Int. J. Med. Pharm. Sci., 2026, 2 (5), 629-632. https://doi.org/10.5281/zenodo.20388086

More related articles
Polymeric Nanoparticles for Oral, Parenteral and T...
Manali Bode, Sanket Bhoyar, Sabiya Sheikh, Rajlaxmi Deolekar, Pri...
Artificial Intelligence in Drug Discovery: Researc...
Vaibhav Shikhare, Vaishnavi Murhe, Sushma Kabra, Renuka Mehasare,...
Artificial Intelligence in Pharmaceutical Industry...
Sunny Deshmukh, Minakshi Londhe, Ashwini Shewale, Ashwini Bankar...
Emerging Advancements in Microneedle Technology in Health Care...
Rosemol K. John, Nishana K. S., Majo Joseph, Anjana C. R., Abigail Joseph , Abhinandh K. S....
Related Articles
A Comprehensive Review on Artificial Intelligence for Accelerating Drug Discover...
Shivshankar Nagrik, Vaishnavi Kamble, Sakshi Tayde, Sakshi Bendarkar, Poonam Tale, Mohini Kale, Jank...
A Review on the Role of Artificial Intelligence in the Pharma Industry...
Vaibhav Shikare, Urmila Ingole, Pavan Idhole, Ashish Gawai...
AI-Driven Stability Testing in Pharmaceutical Industry...
Yashraj Agarkar , Santosh Jain, Prachi Udapurkar , Chanchal Chavan, Akshay Kadam...
Polymeric Nanoparticles for Oral, Parenteral and Transdermal Drug Delivery: Desi...
Manali Bode, Sanket Bhoyar, Sabiya Sheikh, Rajlaxmi Deolekar, Priyanka Sakhare, Prachi Rohit Moon, H...
More related articles
Polymeric Nanoparticles for Oral, Parenteral and Transdermal Drug Delivery: Desi...
Manali Bode, Sanket Bhoyar, Sabiya Sheikh, Rajlaxmi Deolekar, Priyanka Sakhare, Prachi Rohit Moon, H...
Artificial Intelligence in Drug Discovery: Research with Updated Ways...
Vaibhav Shikhare, Vaishnavi Murhe, Sushma Kabra, Renuka Mehasare, Prajakta Chondekar, Gayatri Thakre...
Artificial Intelligence in Pharmaceutical Industry: A Paradigm Shift...
Sunny Deshmukh, Minakshi Londhe, Ashwini Shewale, Ashwini Bankar...
Polymeric Nanoparticles for Oral, Parenteral and Transdermal Drug Delivery: Desi...
Manali Bode, Sanket Bhoyar, Sabiya Sheikh, Rajlaxmi Deolekar, Priyanka Sakhare, Prachi Rohit Moon, H...
Artificial Intelligence in Drug Discovery: Research with Updated Ways...
Vaibhav Shikhare, Vaishnavi Murhe, Sushma Kabra, Renuka Mehasare, Prajakta Chondekar, Gayatri Thakre...
Artificial Intelligence in Pharmaceutical Industry: A Paradigm Shift...
Sunny Deshmukh, Minakshi Londhe, Ashwini Shewale, Ashwini Bankar...